MT695607
Miniopterus fuliginosus isolate N21104 D-loop, partial sequence; mitochondrial.
294
DNA
Miniopterus fuliginosus
N21104
yx52c05.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:265352 3' similar to gb:K00558 TUBULIN ALPHA-1 CHAIN (HUMAN), mRNA sequence.
474
mRNA
Homo sapiens
HZ525885
JP 2016501039-A/21104: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
DD801374
JP 2008525033-A/21104: Group B Streptococcus.
242
PRT
Streptococcus agalactiae
DM795562
JP 2014068652-A/21104: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
FU795585
JP 2009528046-A/21102: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
MD267237
JP 2020517247-A/21104: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
LV566926
JP 2017029159-A/21104: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
PD709018
JP 2021530475-A/21100: De novo Design of Protein Switches.
56
PRT
synthetic construct
LX118720
JP 2017506877-A/21102: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
LF680325
JP 2016521556-A/21104: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
HW186132
JP 2013102767-A/21056: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DJ524904
JP 2010517930-A/21104: Method of constructing and screening libraries of peptide structures.
21
PRT
synthetic construct
OG505290
JP 2018534252-A/21104: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
34
PRT
synthetic construct
OG657490
JP 2021500321-A/21104: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
MC162948
JP 2019500349-A/21104: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
PA391827
JP 2021533803-A/20910: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
MC549604
JP 2019525738-A/21104: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
8
PRT
synthetic construct
OG750623
JP 2021120380-A/21104: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
LF828260
JP 2016528161-A/21093: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
DJ150484
JP 2007228956-A/21102: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
PA336752
JP 2021522188-A/21104: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
PA525588
JP 2022502046-A/8370: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
DL902848
JP 2014205669-A/21104: Method of constructing and screening libraries of peptide structures.
21
PRT
synthetic construct
DJ952378
JP 2010500568-A/39059: ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE.
351
PRT
Homo sapiens
DM757798
JP 2014079248-A/21104: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
MC773214
JP 2018525446-A/21104: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
33
PRT
synthetic construct
HV877645
JP 2010507387-A/21056: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
DL030118
JP 2005512499-A/21104: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
820
DNA
synthetic construct
DL611706
JP 2011092200-A/21104: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria